VITR.ST STO
Vitrolife AB (publ)
1W: -1.5%
1M: -4.8%
3M: +2.6%
YTD: +2.5%
1Y: -33.7%
3Y: -39.0%
5Y: -80.5%
kr 91.80 ($9.14)
-1.05 (-1.13%)
Weekly Expected Move ±3.0%
kr 86
kr 89
kr 92
kr 95
kr 97
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#5
of 32
Medical - Devices
Technical Signal Map
7 Bullish
0 Neutral
6 Bearish
VITR.ST
$12B
Vitrolife AB (publ)
BEARISH
-34
PAX.ST
$1.5B
Paxman AB (publ)
BULLISH
+91
BRAIN.ST
$430M
BrainCool AB (publ)
BULLISH
+91
CEVI.ST
$4.1B
CellaVision AB (publ)
BULLISH
+82
BICO.ST
$1.5B
BICO Group AB (publ)
BULLISH
+41
0YAY.IL
$13B
Vitrolife AB
BULLISH
+34
GETI-B.ST
$68B
Getinge AB (publ)
BULLISH
+32
SECT-B.ST
$59B
Sectra AB (publ)
LEAN BULL
+15
EKTA-B.ST
$19B
Elekta AB (publ)
LEAN BEAR
-24
BACTI-B.ST
$560M
Bactiguard Holding AB (publ)
BEARISH
-34
MCAP.ST
$7.7B
MedCap AB (publ)
BEARISH
-84
SEDANA.ST
$950M
Sedana Medical AB (publ)
BEARISH
-84
XVIVO.ST
$7.1B
Xvivo Perfusion AB (publ)
BEARISH
-87
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| VITR.ST Vitrolife AB (publ) | $12B | -2.5 | -46.5 | 6.0 | 15.1 | -4.2 | 6 | BEARISH | -33.7 |
| PAX.ST Paxman AB (publ) | $1.5B | -303.4 | -1.2 | -1.6 | 2.4 | 34.1 | 3 | BULLISH | -10.3 |
| BRAIN.ST BrainCool AB (publ) | $430M | -9.4 | -24.1 | -22.5 | -73.9 | 5.9 | 2 | BULLISH | 7.8 |
| CEVI.ST CellaVision AB (publ) | $4.1B | 31.2 | 15.1 | 17.0 | 16.3 | -1.6 | 6 | BULLISH | -5.2 |
| BICO.ST BICO Group AB (publ) | $1.5B | -1.9 | -41.8 | -11.2 | -11.1 | -15.5 | 7 | BULLISH | -10.6 |
| 0YAY.IL Vitrolife AB | $13B | — | — | — | — | — | — | BULLISH | — |
| GETI-B.ST Getinge AB (publ) | $68B | 25.1 | 9.0 | 8.4 | 10.0 | -3.6 | 8 | BULLISH | 18.6 |
| SECT-B.ST Sectra AB (publ) | $59B | 88.7 | 28.3 | 82.6 | 16.4 | 13.9 | 5 | LEAN BULL | -16.1 |
| EKTA-B.ST Elekta AB (publ) | $19B | -54.7 | -6.5 | 6.2 | -18.2 | -7.2 | 2 | LEAN BEAR | 8.6 |
| BACTI-B.ST Bactiguard Holding AB (publ) | $560M | -64.2 | -2.9 | -2.8 | -15.2 | -17.8 | 6 | BEARISH | -42.8 |
| MCAP.ST MedCap AB (publ) | $7.7B | 31.9 | 16.4 | 14.9 | 11.4 | 18.5 | 7 | BEARISH | -21.2 |
| SEDANA.ST Sedana Medical AB (publ) | $950M | -27.2 | -4.0 | -2.9 | -19.6 | -0.3 | 5 | BEARISH | -40.7 |
| XVIVO.ST Xvivo Perfusion AB (publ) | $7.1B | 76.0 | 4.1 | 3.8 | 6.8 | 8.8 | 5 | BEARISH | 19.2 |
| VITR.ST Vitrolife AB (publ) | $12B | -2.5 | -46.5 | 6.0 | 15.1 | -4.2 | 6 | BEARISH | -33.7 |
| PAX.ST Paxman AB (publ) | $1.5B | -303.4 | -1.2 | -1.6 | 2.4 | 34.1 | 3 | BULLISH | -10.3 |
| BRAIN.ST BrainCool AB (publ) | $430M | -9.4 | -24.1 | -22.5 | -73.9 | 5.9 | 2 | BULLISH | 7.8 |
| CEVI.ST CellaVision AB (publ) | $4.1B | 31.2 | 15.1 | 17.0 | 16.3 | -1.6 | 6 | BULLISH | -5.2 |
| BICO.ST BICO Group AB (publ) | $1.5B | -1.9 | -41.8 | -11.2 | -11.1 | -15.5 | 7 | BULLISH | -10.6 |
| 0YAY.IL Vitrolife AB | $13B | — | — | — | — | — | — | BULLISH | — |
| GETI-B.ST Getinge AB (publ) | $68B | 25.1 | 9.0 | 8.4 | 10.0 | -3.6 | 8 | BULLISH | 18.6 |
| SECT-B.ST Sectra AB (publ) | $59B | 88.7 | 28.3 | 82.6 | 16.4 | 13.9 | 5 | LEAN BULL | -16.1 |
| EKTA-B.ST Elekta AB (publ) | $19B | -54.7 | -6.5 | 6.2 | -18.2 | -7.2 | 2 | LEAN BEAR | 8.6 |
| BACTI-B.ST Bactiguard Holding AB (publ) | $560M | -64.2 | -2.9 | -2.8 | -15.2 | -17.8 | 6 | BEARISH | -42.8 |
| MCAP.ST MedCap AB (publ) | $7.7B | 31.9 | 16.4 | 14.9 | 11.4 | 18.5 | 7 | BEARISH | -21.2 |
| SEDANA.ST Sedana Medical AB (publ) | $950M | -27.2 | -4.0 | -2.9 | -19.6 | -0.3 | 5 | BEARISH | -40.7 |
| XVIVO.ST Xvivo Perfusion AB (publ) | $7.1B | 76.0 | 4.1 | 3.8 | 6.8 | 8.8 | 5 | BEARISH | 19.2 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
VITR.ST vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F